Literature DB >> 29733338

Persistent Plasmodium falciparum Infection in Women With an Intent to Become Pregnant as a Risk Factor for Pregnancy-associated Malaria.

Nicaise Tuikue Ndam1,2, Bernard Tornyigah1,2, Akpéyédjé Yannelle Dossou3, Guillaume Escriou1, Morten A Nielsen4,5, Ali Salanti4,5, Saadou Issifou3, Achille Massougbodji3, Jean-Philippe Chippaux1,3, Philippe Deloron1.   

Abstract

Background: Pregnant women are more susceptible to Plasmodium falciparum than before pregnancy, and infection has consequences for both mother and offspring. The World Health Organization recommends that pregnant woman in areas of transmission receive intermittent preventive treatment (IPTp) starting in the second trimester. Consequently, women are not protected during the first trimester, although P. falciparum infections are both frequent and harmful.
Methods: A cohort of nulligravid women was followed up during subsequent pregnancy. Malaria was diagnosed by means of microscopy and polymerase chain reaction. Parasites were genotyped at polymorphic loci.
Results: Among 275 nulligravidae enrolled, 68 women became pregnant and were followed up during pregnancy. Before pregnancy, P. falciparum prevalence rates were 15% by microscopy and 66% by polymerase chain reaction. Microscopic infection rates increased to 29% until IPTp administration, and their density increased by 20-fold. Conversely, submicroscopic infection rates decreased. After IPTp administration, all types of infections decreased, but they increased again late in pregnancy. The risk of infection during pregnancy was higher in women with a microscopic (odds ratio, 6.5; P = .047) or submicroscopic (3.06; P = .05) infection before pregnancy and was not related to the season of occurrence. Most infections during pregnancy were persistent infections acquired before pregnancy. Conclusions: Microscopic and submicroscopic malaria infections were frequent in nulligravid women from south Benin. During the first trimester of pregnancy, microscopic infections were more frequent, with a higher parasite density, and mainly derived from parasites infecting the woman before conception. Preventive strategies targeting nonpregnant women with a desire for conception need to be designed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29733338     DOI: 10.1093/cid/ciy380

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Targeting Pregnant Women for Malaria Surveillance.

Authors:  Alfredo Mayor; Clara Menéndez; Patrick G T Walker
Journal:  Trends Parasitol       Date:  2019-08-05

2.  Age-specific patterns of DBLα var diversity can explain why residents of high malaria transmission areas remain susceptible to Plasmodium falciparum blood stage infection throughout life.

Authors:  Shazia Ruybal-Pesántez; Kathryn E Tiedje; Shai Pilosof; Gerry Tonkin-Hill; Qixin He; Thomas S Rask; Lucas Amenga-Etego; Abraham R Oduro; Kwadwo A Koram; Mercedes Pascual; Karen P Day
Journal:  Int J Parasitol       Date:  2022-01-31       Impact factor: 4.330

3.  A Genotyping Study in Benin Comparing the Carriage of Plasmodium falciparum Infections Before Pregnancy and in Early Pregnancy: Story of a Persistent Infection.

Authors:  Sayeh Jafari-Guemouri; Laura Courtois; Atika Mama; Baptiste Rouas; Gabriel Neto Braga; Manfred Accrombessi; Achille Massougbodji; Xavier C Ding; Nicaise Tuikue Ndam; Nadine Fievet; Valérie Briand
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

4.  Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women.

Authors:  Andrew Teo; Louise M Randall; Mwayiwawo Madanitsa; Victor Mwapasa; Linda Kalilani Phiri; Carole Khairallah; Christelle Buffet; Amalia Karahalios; David L Narum; Feiko O Ter Kuile; Stephen J Rogerson
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

Review 5.  Poor Birth Outcomes in Malaria in Pregnancy: Recent Insights Into Mechanisms and Prevention Approaches.

Authors:  Caroline L L Chua; Wina Hasang; Stephen J Rogerson; Andrew Teo
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

6.  Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.

Authors:  Cornélia P A Hounkonnou; Valérie Briand; Nadine Fievet; Manfred Accrombessi; Emmanuel Yovo; Atikatou Mama; Darius Sossou; Bertin Vianou; Achille Massougbodji; Nicaise Tuikue Ndam; Michel Cot; Gilles Cottrell
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

7.  Active case detection of malaria in pregnancy using loop-mediated amplification (LAMP): a pilot outcomes study in South West Ethiopia.

Authors:  Guluma Tadesse; Claire Kamaliddin; Cody Doolan; Ranmalee Amarasekara; Ruth Legese; Abu Naser Mohon; James Cheaveau; Delenasaw Yewhalaw; Dylan R Pillai
Journal:  Malar J       Date:  2020-08-27       Impact factor: 2.979

8.  Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa.

Authors:  Patrick G T Walker; Matt Cairns; Hannah Slater; Julie Gutman; Kassoum Kayentao; John E Williams; Sheick O Coulibaly; Carole Khairallah; Steve Taylor; Steven R Meshnick; Jenny Hill; Victor Mwapasa; Linda Kalilani-Phiri; Kalifa Bojang; Simon Kariuki; Harry Tagbor; Jamie T Griffin; Mwayi Madanitsa; Azra C H Ghani; Meghna Desai; Feiko O Ter Kuile
Journal:  Nat Commun       Date:  2020-07-30       Impact factor: 14.919

9.  Gene expression responses to Zika virus infection in peripheral blood mononuclear cells from pregnant and non-pregnant women.

Authors:  Shen Jean Lim; Andreas Seyfang; Samia Dutra; Bradley Kane; Maureen Groer
Journal:  Microbiologyopen       Date:  2020-11-19       Impact factor: 3.139

10.  Estimating malaria burden among pregnant women using data from antenatal care centres in Tanzania: a population-based study.

Authors:  Chonge Kitojo; Julie R Gutman; Frank Chacky; Emmanuel Kigadye; Sigsbert Mkude; Renata Mandike; Ally Mohamed; Erik J Reaves; Patrick Walker; Deus S Ishengoma
Journal:  Lancet Glob Health       Date:  2019-12       Impact factor: 26.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.